Reports on the discovery of treatment for primary kidney disease by doctors at the Tongji Hospital in Shanghai, China. Usage of herbs and pineal hormones; Efficacy rate of the treatment; Number of required years for treatment.EBSCO_AspChina Today...
• New discoveries of drugs with potential for the treatment of DKD. Abstract Diabetic kidney disease (DKD) is not only one of the main complications of diabetes, but also the leading cause of the end-stage renal disease (ESRD). The occurrence and development of DKD have always been a se...
began thinking about ways to improve the treatment of kidney stones. While some larger stones require surgery, the usual treatment plan is simply to wait for the stones to pass, which takes an average of 10 days. Patients are given painkillers as ...
This year’s focus was on the results of the DELIVER, EMPA-KIDNEY and SURMOUNT-1 trials and their implications for the treatment of heart failure (HF) and chronic kidney disease (CKD) with sodium-glucose cotransporter-2 (SGLT2) inhibitors and obesity with glucose-dependent insulinotropic ...
line here is that we need to be able to select patients better for treatment, so who really needs anti–CTLA-4 in addition to anti–PD-1, and unfortunately in kidney cancer today in 2022, we still do not have any clinically usable molecular markers for treatment selection,” Larkin ...
Treatment of a 1 cm Renal Stones at UPJ (ureteropelvic junction) For kidney stones that are located at the junction of the kidney and the ureter, called the ureteropelvic junction, attempt to pass the stone greater than 5-6 mm would usually be unsuccessful. Certainly stones that 7 mm in...
The CVOT Summit is an annual gathering and discussion forum held in Munich, Germany, and broadcast online. Its primary focus is on the data released annually from cardiovascular, kidney, and metabolic outcomes trials, and it showcases the latest treatment innovations in the areas of diabetes, obe...
(HF) events in patients with type 2 diabetes and chronic kidney disease (Bhatt et al.2021; Pitt et al.2023). Despite its positive impact on glycemic control, the FDA has not approved sotagliflozin for diabetes treatment due to concerns related to diabetic ketoacidosis (Markham and Keam2019)...
There is a need to evaluate the kidney-protective effects of different treatment modalities based on individual characteristics. For example, it would be important to evaluate if different drugs might have a distinct efficacy in patients with DKD with and without albuminuria. Combination therapy with ...
The new visceral adiposity index (NVAI) was superior to previous obesity indices in predicting cardiovascular diseases among Asians. Nevertheless, the utility of the NVAI for predicting chronic kidney disease is still unclear. The objective of this resea